Project Number 5U01NS078034-03 Agency/Funding Organization NINDS Funding Year 2014 View Full Project Details for PDE4D ALLOSTERIC MODULATORS FOR TREATING COGNITIVE IMPAIRMENT Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator GURNEY, MARK E Principal Investigator First Name MARK E Principal Investigator Last Name GURNEY Awardee Organization TETRA DISCOVERY PARTNERS, LLC Awardee State Michigan Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-NS-12-002: NIH BLUEPRINT FOR NEUROSCIENCE RESEARCH GRAND CHALLENGE: DEVELOPING NOVEL DRUGS FOR DISORDERS OF THE NERVOUS SYSTEM (U01) FY Overall Cost $235,406 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Related Resources Patent Heteroaryl inhibitors of PDE4
